United States Androgens Market Report 2017

December 2017 | 100 pages | ID: U9E5560C7F0EN
QYResearch

Abstracts

In this report, the United States Androgens market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Androgens in these regions, from 2012 to 2022 (forecast).

United States Androgens market competition by top manufacturers/players, with Androgens sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Sanofi-Aventis
• Abbott
• Dendreon
• AstraZeneca
• Anabolics
• ABBVIE
• Wuhan Nuohui Pharmaceutical And Chwmical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Solution
• Implant
• Capsule
• Kit
• Tablet
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Anemias
• Delayed Growth Spurt
• Lichen Sclerosus
• Microphallus
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Androgens Market Report 2017

1 ANDROGENS OVERVIEW

1.1 Product Overview and Scope of Androgens
1.2 Classification of Androgens by Product Category
  1.2.1 United States Androgens Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Androgens Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Solution
  1.2.4 Implant
  1.2.5 Capsule
  1.2.6 Kit
  1.2.7 Tablet
  1.2.8 Other
1.3 United States Androgens Market by Application/End Users
  1.3.1 United States Androgens Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Anemias
  1.3.3 Delayed Growth Spurt
  1.3.4 Lichen Sclerosus
  1.3.5 Microphallus
  1.3.6 Other
1.4 United States Androgens Market by Region
  1.4.1 United States Androgens Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Androgens Status and Prospect (2012-2022)
  1.4.3 Southwest Androgens Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Androgens Status and Prospect (2012-2022)
  1.4.5 New England Androgens Status and Prospect (2012-2022)
  1.4.6 The South Androgens Status and Prospect (2012-2022)
  1.4.7 The Midwest Androgens Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Androgens (2012-2022)
  1.5.1 United States Androgens Sales and Growth Rate (2012-2022)
  1.5.2 United States Androgens Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANDROGENS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Androgens Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Androgens Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Androgens Average Price by Players/Suppliers (2012-2017)
2.4 United States Androgens Market Competitive Situation and Trends
  2.4.1 United States Androgens Market Concentration Rate
  2.4.2 United States Androgens Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Androgens Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANDROGENS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Androgens Sales and Market Share by Region (2012-2017)
3.2 United States Androgens Revenue and Market Share by Region (2012-2017)
3.3 United States Androgens Price by Region (2012-2017)

4 UNITED STATES ANDROGENS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Androgens Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Androgens Revenue and Market Share by Type (2012-2017)
4.3 United States Androgens Price by Type (2012-2017)
4.4 United States Androgens Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANDROGENS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Androgens Sales and Market Share by Application (2012-2017)
5.2 United States Androgens Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANDROGENS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Androgens Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi-Aventis
  6.2.2 Androgens Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi-Aventis Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abbott
  6.3.2 Androgens Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abbott Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dendreon
  6.4.2 Androgens Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dendreon Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca
  6.5.2 Androgens Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Anabolics
  6.6.2 Androgens Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Anabolics Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 ABBVIE
  6.7.2 Androgens Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 ABBVIE Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Wuhan Nuohui Pharmaceutical And Chwmical
  6.8.2 Androgens Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Wuhan Nuohui Pharmaceutical And Chwmical Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ANDROGENS MANUFACTURING COST ANALYSIS

7.1 Androgens Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Androgens

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Androgens Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Androgens Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANDROGENS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Androgens Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Androgens Sales Volume Forecast by Type (2017-2022)
11.3 United States Androgens Sales Volume Forecast by Application (2017-2022)
11.4 United States Androgens Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Androgens
Figure United States Androgens Market Size (Units) by Type (2012-2022)
Figure United States Androgens Sales Volume Market Share by Type (Product Category) in 2016
Figure Solution Product Picture
Figure Implant Product Picture
Figure Capsule Product Picture
Figure Kit Product Picture
Figure Tablet Product Picture
Figure Other Product Picture
Figure United States Androgens Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Androgens by Application in 2016
Figure Anemias Examples
Table Key Downstream Customer in Anemias
Figure Delayed Growth Spurt Examples
Table Key Downstream Customer in Delayed Growth Spurt
Figure Lichen Sclerosus Examples
Table Key Downstream Customer in Lichen Sclerosus
Figure Microphallus Examples
Table Key Downstream Customer in Microphallus
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Androgens Market Size (Million USD) by Region (2012-2022)
Figure The West Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Androgens Sales (Units) and Growth Rate (2012-2022)
Figure United States Androgens Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Androgens Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Androgens Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Androgens Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Androgens Sales Share by Players/Suppliers
Figure 2017 United States Androgens Sales Share by Players/Suppliers
Figure United States Androgens Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Androgens Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Androgens Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Androgens Revenue Share by Players/Suppliers
Figure 2017 United States Androgens Revenue Share by Players/Suppliers
Table United States Market Androgens Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Androgens Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Androgens Market Share of Top 3 Players/Suppliers
Figure United States Androgens Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Androgens Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Androgens Product Category
Table United States Androgens Sales (Units) by Region (2012-2017)
Table United States Androgens Sales Share by Region (2012-2017)
Figure United States Androgens Sales Share by Region (2012-2017)
Figure United States Androgens Sales Market Share by Region in 2016
Table United States Androgens Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Androgens Revenue Share by Region (2012-2017)
Figure United States Androgens Revenue Market Share by Region (2012-2017)
Figure United States Androgens Revenue Market Share by Region in 2016
Table United States Androgens Price (K USD/Unit) by Region (2012-2017)
Table United States Androgens Sales (Units) by Type (2012-2017)
Table United States Androgens Sales Share by Type (2012-2017)
Figure United States Androgens Sales Share by Type (2012-2017)
Figure United States Androgens Sales Market Share by Type in 2016
Table United States Androgens Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Androgens Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Androgens by Type (2012-2017)
Figure Revenue Market Share of Androgens by Type in 2016
Table United States Androgens Price (K USD/Unit) by Types (2012-2017)
Figure United States Androgens Sales Growth Rate by Type (2012-2017)
Table United States Androgens Sales (Units) by Application (2012-2017)
Table United States Androgens Sales Market Share by Application (2012-2017)
Figure United States Androgens Sales Market Share by Application (2012-2017)
Figure United States Androgens Sales Market Share by Application in 2016
Table United States Androgens Sales Growth Rate by Application (2012-2017)
Figure United States Androgens Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Androgens Sales Growth Rate (2012-2017)
Figure Pfizer Androgens Sales Market Share in United States (2012-2017)
Figure Pfizer Androgens Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Androgens Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis Androgens Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis Androgens Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Androgens Sales Growth Rate (2012-2017)
Figure Abbott Androgens Sales Market Share in United States (2012-2017)
Figure Abbott Androgens Revenue Market Share in United States (2012-2017)
Table Dendreon Basic Information List
Table Dendreon Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Androgens Sales Growth Rate (2012-2017)
Figure Dendreon Androgens Sales Market Share in United States (2012-2017)
Figure Dendreon Androgens Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Androgens Sales Growth Rate (2012-2017)
Figure AstraZeneca Androgens Sales Market Share in United States (2012-2017)
Figure AstraZeneca Androgens Revenue Market Share in United States (2012-2017)
Table Anabolics Basic Information List
Table Anabolics Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Anabolics Androgens Sales Growth Rate (2012-2017)
Figure Anabolics Androgens Sales Market Share in United States (2012-2017)
Figure Anabolics Androgens Revenue Market Share in United States (2012-2017)
Table ABBVIE Basic Information List
Table ABBVIE Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure ABBVIE Androgens Sales Growth Rate (2012-2017)
Figure ABBVIE Androgens Sales Market Share in United States (2012-2017)
Figure ABBVIE Androgens Revenue Market Share in United States (2012-2017)
Table Wuhan Nuohui Pharmaceutical And Chwmical Basic Information List
Table Wuhan Nuohui Pharmaceutical And Chwmical Androgens Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Wuhan Nuohui Pharmaceutical And Chwmical Androgens Sales Growth Rate (2012-2017)
Figure Wuhan Nuohui Pharmaceutical And Chwmical Androgens Sales Market Share in United States (2012-2017)
Figure Wuhan Nuohui Pharmaceutical And Chwmical Androgens Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgens
Figure Manufacturing Process Analysis of Androgens
Figure Androgens Industrial Chain Analysis
Table Raw Materials Sources of Androgens Major Players/Suppliers in 2016
Table Major Buyers of Androgens
Table Distributors/Traders List
Figure United States Androgens Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Androgens Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Androgens Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Androgens Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Androgens Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Androgens Sales Volume (Units) Forecast by Type in 2022
Table United States Androgens Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Androgens Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Androgens Sales Volume (Units) Forecast by Application in 2022
Table United States Androgens Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Androgens Sales Volume Share Forecast by Region (2017-2022)
Figure United States Androgens Sales Volume Share Forecast by Region (2017-2022)
Figure United States Androgens Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources